A complex fracturing at Bone brings together inflammatory, orthopedic biotechs in reverse merger-type deal

The orthopedics-focused biotech was out looking for, well, a bone. And it found one in Medsenic, which will combine with Bone Therapeutics in an all-stock, reverse merger-type deal that will create a newly named company: BioSenic.